The importance of measuring troponin at the point of care

Radiometer and acutecaretesting.org present a FREE WEBINAR!

Get the on-demand recorded version here.

Thanks to improved knowledge of the pathology of acute myocardial infarction (AMI) and the technological development and refinements of troponin immuno-assays, the cardiac regulatory proteins troponin T and I have replaced the conventional cardiac markers - CKMB, CK, ASAT and LD - as the biomarker of choice in the diagnosis of AMI.

Regardless of whether your institution chooses to measure troponin T or I, the guidelines set in the diagnostic criteria consensus of the European Society of Cardiology and the American College of Cardiology have helped troponin to be considered the most definitive method of AMI detection.

Guidelines advocate a turn-around-time of less than 60 minutes in diagnosing acute coronary syndrome (ACS). Performing troponin measurements in the hospital’s central lab can take considerable valuable time before results are reported to the clinicians. At the point of care, troponin testing is extremely accurate and available in 20 minutes. Faster analysis leads to more immediate treatment resulting in significantly improved patient outcome. In addition, if troponin tests rule out AMI, faster test results can shorten patients’ length of stay, which substantially increases hospital efficiency.

In this webinar, Dr. Ravkilde will discuss the current state of AMI diagnosis using the troponin biomarker, and review the recent advances that have led to such improved accuracy and speed in its measurement at the point of care.

Get the on-demand recorded version here.

About the presenter

Jan Ravkilde, MD, DMSc, FESC, FACC is an Associate Professor, Chief Physician and the Head of the Cardiology Invasive Section in the Department of Cardiology, Heart Center Aalborg, at Aarhus University Hospital in Aalborg, Denmark. He has been awarded Gold prize dissertations and is a fellow of both the European Society of Cardiology and the American College of Cardiology.

As Head of Clinical Cardiology Research at Aarhus University Hospital, Dr. Ravkilde has conducted numerous study visits to Research Centers of Cardiology, Thoracic Surgery, and Clinical Biochemistry in Europe and United States. A frequent Lecturer and invited speaker at various international congresses, courses and symposia, Dr. Ravkilde has performed more than 8500 heart catheterizations, percutaneous coronary interventions, and right heart catheterizations. He has authored both cardiology books and more than 80 articles in peer-reviewed international Journals.

This webinar will:

• Present guidelines for troponin testing turn-around-time and differentiate between central lab and point of care measurement time and accuracy
• Differentiate between the troponin T and troponin I and compare their effectiveness as cardiac biomarkers
• Discuss the advancements made from fourth generation to fifth generation troponin T testing
• Review the new universal definition of MI, especially type 2 MI
• Highlight the importance of serial measurements in diagnosing AMI in accordance with guidelines 

Who should attend?

• Cardiologists
• Hospital laboratorians
• Point of care coordinators
• Emergency physicians
• Critical care clinicians

Questions?

Call  +1 434 202 8365 or email info@whitehatcom.com